Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
103.89x
As of Dec 29, 2023
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Dec 29, 2023 | 103.89x |
| Dec 28, 2023 | 101.35x |
| Dec 27, 2023 | 102.73x |
| Dec 26, 2023 | 104.92x |
| Dec 22, 2023 | 102.94x |
| Dec 21, 2023 | 105.04x |
| Dec 20, 2023 | 106.23x |
| Dec 19, 2023 | 109.66x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison